Epoetin Theta with a New Dosing Schedule in Anaemic Cancer Patients Receiving Nonplatinum-Based Chemotherapy: A Randomised Controlled Trial

INTRODUCTION: Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo in a randomised, double-blind clinical trial in adult cancer patients receiving nonplatinum-based chem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tjulandin, Sergei A, Bias, Peter, Elsässer, Reiner, Gertz, Beate, Kohler, Erich, Buchner, Anton
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Inc 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3193379/
https://ncbi.nlm.nih.gov/pubmed/22022341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1753-5174.2011.00035.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados